Nephrocare Healt

{
  "main_header": {
    "sid": 10039897,
    "name": "Nephrocare Healt",
    "stock_name": "Nephrocare Healt",
    "full_name": "Nephrocare Health Services Ltd",
    "name_url": "stocks-analysis/nephrocare-healt",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "614.35",
    "chg": -36.1,
    "chgp": "-5.55%",
    "dir": -1,
    "prev_price": "650.45",
    "mcapval": "6,169.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544647,
    "symbol": "NEPHROPLUS",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "India SENSEX",
    "isin": "INE428V01029",
    "curr_date": "May 20",
    "curr_time": "",
    "bse_nse_vol": "6.38 lacs",
    "exc_status": "Active",
    "traded_date": "May 20, 2026",
    "traded_date_str": "2026 05 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/nephrocare-healt-10039897-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Nephrocare Health Services Q4 FY26: Premium Valuation Concerns Overshadow Robust Growth",
        "link": "https://www.marketsmojo.com/news/result-analysis/nephrocare-health-services-q4-fy26-premium-valuation-concerns-overshadow-robust-growth-4001530",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NephrocareHealt_quaterlyResult_4001530.png",
        "date": "2026-05-20 16:55:38",
        "description": "Nephrocare Health Services Ltd., India's leading dialysis services provider, delivered a strong operational performance in Q4 FY26 with consolidated net profit rising 51.02% year-on-year to ₹30.37 crores, driven by robust revenue expansion and improved operational efficiency. However, the stock faced selling pressure, declining 5.55% to ₹614.35 on May 20, 2026, as investors grappled with stretched valuation multiples that have pushed the company's price-to-earnings ratio to an elevated 79x – significantly above the healthcare services sector average of 63x."
      }
    ],
    "total": 1,
    "sid": "10039897",
    "stock_news_url": "https://www.marketsmojo.com/news/nephrocare-health-services-10039897"
  },
  "announcements": [
    {
      "caption": "Re-Appointment Of Internal Auditor",
      "datetime": "19-May-2026",
      "details": "The Board of Directors at its meeting held on May 19 2026 has re-appointed M/s. BDO India LLP as Internal Auditor as per the disclosure annexed herewith.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "19-May-2026",
      "details": "Please find attached herewith Investor Presentation for quarter and year ended March 31 2026.",
      "source": "BSE"
    },
    {
      "caption": "Issuance Of Corporate Guarantee",
      "datetime": "19-May-2026",
      "details": "This is to inform you that the Board of Directors in its meeting held on has approved and granted in-principal approval for providing corporate guarantee as per the disclosure annexed herewith.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Nephrocare Health Services Q4 FY26: Premium Valuation Concerns Overshadow Robust Growth

2026-05-20 16:55:38

Nephrocare Health Services Ltd., India's leading dialysis services provider, delivered a strong operational performance in Q4 FY26 with consolidated net profit rising 51.02% year-on-year to ₹30.37 crores, driven by robust revenue expansion and improved operational efficiency. However, the stock faced selling pressure, declining 5.55% to ₹614.35 on May 20, 2026, as investors grappled with stretched valuation multiples that have pushed the company's price-to-earnings ratio to an elevated 79x – significantly above the healthcare services sector average of 63x.

Read full news article

View All News